Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Dow
Baxter
Merck

Last Updated: November 28, 2022

CLINICAL TRIALS PROFILE FOR LOSARTAN POTASSIUM


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Losartan Potassium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00090259 ↗ Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) Completed Merck Sharp & Dohme Corp. Phase 3 2001-12-19 This is a multicenter study to evaluate potential decrease in hospitalization events and time between events and increasing longevity in patients with symptomatic congestive heart failure and intolerant of first-line medication for heart failure. This study will evaluate if higher doses of the investigational drug given daily will be superior to the lower dose of the same investigational drug given daily.
NCT00140907 ↗ ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 4 2000-03-14 To demonstrate that losartan (+ conventional therapy) compared to placebo (+ conventional therapy) will reduce the number of RT patients who experience histological lesions of chronic allograft nephropathy
NCT00140985 ↗ Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) Completed Merck Sharp & Dohme Corp. Phase 4 2000-02-01 Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Losartan Potassium

Condition Name

Condition Name for Losartan Potassium
Intervention Trials
Hypertension 33
Healthy 8
Essential Hypertension 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Losartan Potassium
Intervention Trials
Hypertension 35
Essential Hypertension 8
Kidney Diseases 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Losartan Potassium

Trials by Country

Trials by Country for Losartan Potassium
Location Trials
United States 114
China 22
India 4
Brazil 3
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Losartan Potassium
Location Trials
California 11
Texas 10
Ohio 7
New York 5
Missouri 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Losartan Potassium

Clinical Trial Phase

Clinical Trial Phase for Losartan Potassium
Clinical Trial Phase Trials
Phase 4 18
Phase 3 18
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Losartan Potassium
Clinical Trial Phase Trials
Completed 58
Terminated 7
Recruiting 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Losartan Potassium

Sponsor Name

Sponsor Name for Losartan Potassium
Sponsor Trials
Merck Sharp & Dohme Corp. 21
Roxane Laboratories 4
Torrent Pharmaceuticals Limited 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Losartan Potassium
Sponsor Trials
Other 50
Industry 49
NIH 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Mallinckrodt
Merck
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.